Authors:
PAWLOTSKY JM
DEGENDT S
BEAUCOURT S
GONCALES FL
BUTTERWORTH LA
COOKSLEY WGE
GISH RG
GANNECARRIE N
BEAUGRAND M
FAY F
FAY O
GONZALEZ JE
MARTINS RMB
DHUMEAUX D
VANDERBORGHT B
STUYVER L
Citation: Jm. Pawlotsky et al., WORLDWIDE SPREAD OF HEPATITIS-C VIRUS GENOTYPE 3A AMONG INTRAVENOUS-DRUG-USERS, Hepatology, 28(4), 1998, pp. 1604-1604
Authors:
HYLAND CA
MISON L
SOLOMON N
COCKERILL J
WANG L
HUNT J
SELVEY LA
FAOAGALI J
COOKSLEY WGE
YOUNG IF
TROWBRIDGE R
BORTHWICK I
GOWANS EJ
Citation: Ca. Hyland et al., EXPOSURE TO GB VIRUS TYPE-C OR HEPATITIS-G VIRUS IN SELECTED AUSTRALIAN ADULT AND CHILDREN POPULATIONS, Transfusion, 38(9), 1998, pp. 821-827
Authors:
COOKSLEY WGE
MCIVOR C
WATSON K
SMITH B
JACKSON P
BROTODIHARDJO A
FARRELL GC
JONES DB
NGU M
MCCAUGHAN GW
OBRIEN E
KAVANAGH J
MORROW AW
DUDLEY F
CROMIE S
JENKINS P
HARLEY H
SHAW D
BATEY RG
CREWE E
BOWDEN S
LOCARNINI S
CUNNINGHAM A
Citation: Wge. Cooksley et al., EFFICACY AND TOLERANCE OF A 6-MONTH TREATMENT COURSE OF DAILY INTERFERON-ALPHA-2A FOR CHRONIC HEPATITIS-C WITH CIRRHOSIS, Journal of viral hepatitis, 4(5), 1997, pp. 317-323
Citation: Wge. Cooksley et al., TREATMENT OF CIRRHOTIC HEPATITIS-C VIRUS PATIENTS WITH DAILY DOSES OFINTERFERON-ALPHA(2A), Journal of viral hepatitis, 4, 1997, pp. 75-78
Authors:
LADHAMS AM
ARNOLD ST
COOKSLEY WGE
SING GK
Citation: Am. Ladhams et al., KINETICS OF HEPATITIS-B SPECIFIC CYTOTOXIC T-LYMPHOCYTES DURING THE CLINICAL COURSE OF CHRONIC ACTIVE HEPATITIS-B, Hepatology, 26(4), 1997, pp. 766-766
Authors:
STUART KA
BUSFIELD F
JAZWINSKA EC
GIBSON P
BUTTERWORTH LA
COOKSLEY WGE
POWELL LW
CRAWFORD DHG
Citation: Ka. Stuart et al., THE C282Y MUTATION IN HFE IS COMMON IN AUSTRALIAN PATIENTS AND CAN ACT INDEPENDENTLY OF HCV TO PRECIPITATE PORPHYRIA-CUTANEA-TARDA, Hepatology, 26(4), 1997, pp. 1911-1911
Citation: La. Butterworth et al., COMPARISON OF 4 METHODS FOR QUANTITATIVE MEASUREMENT OF HEPATITIS-B VIRAL-DNA, Journal of hepatology, 24(6), 1996, pp. 686-691
Citation: Wge. Cooksley et Ca. Mcivor, FIBROSING CHOLESTATIC HEPATITIS AND HBV AFTER BONE-MARROW TRANSPLANTATION, Biomedicine & pharmacotherapy, 49(3), 1995, pp. 117-124
Authors:
FARRELL GC
COOKSLEY WGE
DUDLEY FJ
WATSON K
Citation: Gc. Farrell et al., INTENSIVE 6-MONTH COURSE OF INTERFERON TREATMENT FOR CHRONIC HEPATITIS-C AND CIRRHOSIS, Hepatology, 22(4), 1995, pp. 46-46
Citation: Wge. Cooksley et L. Wolfe, LONG-TERM FOLLOW-UP OF 364 PATIENTS TREATED WITH INTERFERON ALPHA-2A FOR CHRONIC HEPATITIS-C - ROLE OF GENOTYPE AND VIREMIA, Hepatology, 22(4), 1995, pp. 270-270
Authors:
MARCELLIN P
FERENCI P
GERKEN G
FEVERY J
HADZIYANNIS S
SETTE H
GEUBEL A
TASSOUPOULOS N
COOKSLEY WGE
FARREL G
DIENES HP
CHANEAC M
Citation: P. Marcellin et al., RANDOMIZED STUDY COMPARING A FIXED-DOSE OF ALPHA-INTERFERON WITH AN ESCALATING DOSE SCHEDULE IN PATIENTS WITH CHRONIC HEPATITIS-B, Hepatology, 22(4), 1995, pp. 878-878
Authors:
RAMM GA
GIBBONS JC
BUTTERWORTH LA
CRAWFORD DHG
WALKER NI
COOKSLEY WGE
Citation: Ga. Ramm et al., CORRELATION BETWEEN HEPATIC STELLATE CELL ACTIVATION AND HEPATITIS-C VIRUS GENOTYPE, VIRAL LOAD AND RESPONSE TO INTERFERON THERAPY, Hepatology, 22(4), 1995, pp. 1488-1488
Authors:
MIZOGUCHI N
MIZOKAMI M
ORITO E
KOHARA M
LIN HH
CHEN DS
FANG ZX
YOON SK
KIM BS
COOKSLEY WGE
DAVIS GL
TIBBS CJ
WILLIAMS R
LAU JYN
Citation: N. Mizoguchi et al., DISTRIBUTION OF HEPATITIS-C VIRUS (HCV) SEROLOGICALLY DEFINED GENOTYPES IN 4 CONTINENTS, Hepatology, 20(4), 1994, pp. 10000246-10000246
Citation: Wge. Cooksley et La. Butterworth, HEPATITIS-C IN HEALTH-CARE WORKERS - COMMUNITY ACQUISITION OR OCCUPATIONAL EXPOSURE, Hepatology, 20(4), 1994, pp. 10000249-10000249
Authors:
SELVEY LA
SRIRAJALINGAN M
CRAWFORD D
LEGGETT B
COOKSLEY WGE
Citation: La. Selvey et al., ALCOHOL DOES NOT PLAY A SIGNIFICANT ROLE IN PROMOTING CIRRHOSIS IN CHRONIC HEPATITIS-C - ANALYSIS OF 102 PATIENTS, Hepatology, 20(4), 1994, pp. 10000254-10000254
Authors:
SING GK
PACE R
PRIOR S
SCOTT JSD
SHIELD P
MARTIN N
SEARLE J
BATTERSBY C
POWELL LW
COOKSLEY WGE
Citation: Gk. Sing et al., ESTABLISHMENT OF A CELL-LINE FROM A HEPATOCELLULAR-CARCINOMA FROM A PATIENT WITH HEMOCHROMATOSIS, Hepatology, 20(1), 1994, pp. 74-81
Citation: T. Chai et al., INFECTION OF HUMAN BONE-MARROW STROMAL CELLS BY HEPATITIS-B VIRUS - IMPLICATIONS FOR VIRAL PERSISTENCE AND THE SUPPRESSION OF HEMATOPOIESIS, The Journal of infectious diseases, 169(4), 1994, pp. 871-874
Citation: D. Sankaran et al., THE EXPRESSION OF VIRAL MARKERS IN PERIPHERAL-BLOOD MONOCYTES INFECTED WITH HEPATITIS-B VIRUS IN-VITRO, Journal of leukocyte biology, 1993, pp. 46-46
Citation: G. Sing et al., PRODUCTION OF HEPATITIS-B VIRUS IN LEUKEMIC-CELL LINES TRANSFECTED WITH THE VIRAL GENOME, Journal of leukocyte biology, 1993, pp. 47-47
Authors:
MCIVOR C
COOKSLEY WGE
WALKER N
PACE R
KERLIN P
STRONG R
LYNCH S
Citation: C. Mcivor et al., HEPATITIS-B VIRUS (HBV) PRECORE MUTANT ASSOCIATED WITH FIBROSING CHOLESTATIC HEPATITIS AFTER ORTHOTOPIC LIVER-TRANSPLANT (OLT), Hepatology, 18(4), 1993, pp. 10000337-10000337
Citation: Dhg. Crawford et al., DISTRIBUTION OF BODY-WATER IN PATIENTS WITH CIRRHOSIS - THE EFFECT OFLIVER-TRANSPLANTATION, Hepatology, 17(6), 1993, pp. 1016-1021